CME webinar series: Addiction Care for the Non-Addiction Provider
Sep. 2022Education/Webinars
"CME webinar series: Addiction Care for the Non-Addiction Provider
September is National Recovery Month, and you are invited to watch a timely, CME-accredited webinar series on the topic. Michael Lynch, MD, Medical Director, Pittsburgh Poison Center; Medical Director, UPMC Health Plan Substance Use Disorder Services; and Associate Professor of Emergency Medicine, Toxicology, Pediatrics, and Addiction at the University of Pittsburgh, leads this four-part series.
Watch these recorded webinars to build your knowledge base:
*Provider is responsible for verifying CME eligibility. *This activity is approved for the following credit: AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity."
-
Part 1: Screening and initial intervention
Learn about the physiology, stigma, and effects of substance use disorder, among other topics related to screening and intervention. -
Part 2: Alcohol use disorder management
Learn about medication management and non-medication interventions, among other aspects of alcohol use disorder. -
Part 3: Opioid use disorder management
Learn about recommending medications for opioid use disorder (MOUD) and different MOUD options, among other aspects of opioid use disorder. -
Part 4: Overview of management and available resources
Learn about continuum of care for a patient with a substance use disorder including available resources to assist non-addiction providers to meet the needs of these patients.
*Provider is responsible for verifying CME eligibility. *This activity is approved for the following credit: AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity."
Recent Announcements
Medical device correction: FreeStyle Libre 3 (Abbott – December)
Abbott has announced a medical device correction for certain FreeStyle Libre 3 sensors. These sensors monitor blood glucose levels as part of the FreeStyle Libre system, which includes a sensor, reader, and app. The correction applies only to the sensor. No other Libre products or Abbott biowearables are affected.Dec. 2025Pharmacy Updates
CME Webinar: The State of Telehealth in 2026
Please join us for a live, CME-accredited webinar on Tuesday, Jan. 27, from noon to 1 p.m. that will share updates on the state of telehealth for 2026.Dec. 2025Education/Webinars
Formulary updates effective Jan. 1, 2026
Review upcoming policy and operational updatesDec. 2025Pharmacy Updates